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ERdj5 is a member of the protein disulfide isom-
erase family of proteins localized to the endo-
plasmic reticulum (ER) of mammalian cells. To
date, only a limited number of substrates for ERdj5
are known. Here we identify a number of endoge-
nous substrates that form mixed disulfides with
ERdj5, greatly expanding its client repertoire.
ERdj5 previously had been thought to exclusively
reduce disulfides in proteins destined for dislocation
to the cytosol for degradation. However, we demon-
strate here that for one of the identified substrates,
the low-density lipoprotein receptor (LDLR), ERdj5
is required not for degradation, but rather for effi-
cient folding. Our results demonstrate that the
crucial role of ERdj5 is to reduce non-native disul-
fides formed during productive folding and that
this requirement is dependent on its interaction
with BiP. Hence, ERdj5 acts as the ER reductase,
both preparing misfolded proteins for degradation
and catalyzing the folding of proteins that form
obligatory non-native disulfides.
INTRODUCTION
ERdj5 is an endoplasmic reticulum (ER)-localized oxidoreduc-
tase that contains a J domain as well as six thioredoxin
domains, four of which are responsible for its disulfide ex-
change activity (Cunnea et al., 2003; Hosoda et al., 2003).
Our existing knowledge of the function of ERdj5 indicates a
role in ER-associated degradation (ERAD) (Dong et al., 2008;
Ushioda et al., 2008). It has been shown to interact with com-
ponents of the degradation pathway (Christianson et al., 2012;
Hagiwara et al., 2011), in particular EDEM1, which recognizes
proteins destined for degradation and targets them to the ER
membrane for subsequent dislocation into the cytosol (Cormier
et al., 2009; Groisman et al., 2011). Overexpression of wild-type
(WT), but not an active-site mutant of ERdj5, accelerates the
degradation of model proteins such as the null Hong KongM(NHK) variant of a1 antitrypsin and the J chain of immunoglob-
ulin M (IgM) (Ushioda et al., 2008). Both of these proteins form
intermolecular disulfides that need to be reduced for the protein
to be degraded efficiently. The accelerated degradation of
these substrates was prevented by the inclusion of a drug
that inhibits trimming of the oligosaccharide side chain. As
this trimming event is required for glycoproteins to be recog-
nized by the machinery for ERAD (Wilson et al., 2000), this
result indicates that it is the physical association of ERdj5
with EDEM1 that targets the substrate for disulfide reduction.
Hence, ERdj5 is thought to catalyze the reduction of disulfides
in substrates already targeted for degradation, an activity that
prepares the protein for subsequent passage through the ER
membrane.
In addition to its interaction with EDEM1, ERdj5 also binds to
the ER-localized Hsp70 homolog BiP (Cunnea et al., 2003; Ush-
ioda et al., 2008). Binding is ATP dependent and requires the J
domain, as its removal prevents BiP binding. The sequence
HPD within the J domain is known to mediate binding to
Hsp70. As expected, BiP binding was prevented when this
sequence in ERdj5 wasmutated toQPD. Blocking the interaction
between ERdj5 and BiP prevented the accelerated degradation
of model substrates caused by overexpression of ERdj5, indi-
cating that this oxidoreductase functions during degradation
by binding to BiP.
The ER oxidoreductases are a large family of disulfide
exchange proteins characterized by the presence of at least
one catalytically active thioredoxin domain containing a CXXC
motif (Ellgaard and Ruddock, 2005). ERdj5 is distinct in this
family not only for the presence of a J domain but also due to
the reduction potential of its active-site cysteines. While there
is some variability of reduction potential between the four
active-site disulfides in ERdj5, they are generally more stable
than other protein disulfide isomerase (PDI) family members
and are more likely to accept electrons and act as reducing
agents (Ushioda et al., 2008). Studies with the purified protein
have shown that, although it is able to reduce disulfides in sub-
strates, it does not catalyze disulfide formation or the isomeriza-
tion of non-native disulfides (Ushioda et al., 2008). Hence, the
biophysical properties and the in vitro analysis of ERdj5 are
consistent with its role as a reductase in the cell.
To date, the number of known protein substrates for ERdj5 is
quite limited and is focused on those that require disulfideolecular Cell 50, 793–804, June 27, 2013 ª2013 Elsevier Inc. 793
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Figure 1. ERdj5 Substrate-Trapping Mutant
Forms Mixed Disulfides with Proteins
Entering the Secretory Pathway
(A) Schematic of the various ERdj5 constructs
used in this study depicting the domain organi-
zation of ERdj5 engineered with a C-terminal V5
tag but retaining a C-terminal KDEL sequence.
Trx1–Trx4 are the thioredoxin domains with active
sites as indicated, whereas Trxb1 and Trxb2 are
thioredoxin domains without active sites.
(B) Confocal immunofluorescence microscopy of
HT1080 cells stably expressing ERdj5 C/A. Cells
were fixed and stained with antibodies to the V5
epitope tag (green) and to an ER-localized protein
PDI (red).
(C) Cell lysates from HT1080 cells, either
untransfected (UT), transiently expressing ERdj5
WT, or stably expressing ERdj5 C/A, separated
under reducing (R) or nonreducing (NR) conditions
were immunoblotted using the V5 antibody to
detect the exogenously expressed ERdj5.
(D) ERdj5 C/A was immunoisolated with the V5
antibody from cell lysates of HT1080 cells either
untransfected (UT) or stably expressing ERdj5
C/A. Immunoisolates were analyzed by immuno-
blotting with antibodies to endogenous ER pro-
teins and LDLR as indicated. HC and LC (anti-BiP
and anti-Ero1 blots) indicate immunoglobulin
heavy and light chains, respectively.
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Role of ERdj5 in LDLR Folding and Secretionreduction prior to degradation. One approach that has been
used in the past to identify novel substrates for PDI family mem-
bers involves the expression of mutant enzymes in which the
second cysteine in the active site has been mutated to alanine
(Jessop et al., 2009a). Such a CXXA active site is unable to
resolve any disulfides formed between enzyme and substrate,
thereby allowing the isolation of disulfide-linked complexes.
The isolated substrate can then be identified by mass spectrom-
etry. Here we have carried out such an approach with ERdj5,
thereby greatly expanding its potential substrate repertoire.
One particular isolated substrate, the low-density lipoprotein
receptor (LDLR), is known to form non-native disulfides during
its folding pathway (Jansens et al., 2002). We show here that
rather than being involved in the degradation of the LDLR,
ERdj5 is in fact required for its efficient folding and secretion.
Such a role for ERdj5 was unexpected and reveals the versatility
of the PDI family in their biological functions.794 Molecular Cell 50, 793–804, June 27, 2013 ª2013 Elsevier Inc.RESULTS
Increasing the Repertoire of Known
Substrates for ERdj5
To identify the endogenous substrates
of ERdj5, we created a stable cell line
expressing a version of the enzyme that
contained a CXXC-to-CXXA mutation at
each of the four active sites (ERdj5 C/A:
Figure 1A). Such active-site mutants of
the thioredoxin family of proteins have
been used previously to trap substrates
in covalent complexes with the enzyme(Jessop et al., 2007, 2009b; Zito et al., 2010). We also appended
a V5 epitope tag at the C terminus prior to the KDEL retention
sequence to allow the identification and immunoisolation of the
exogenously expressed protein. We confirmed that the protein
was expressed and localized to the ER by immunofluorescent
microscopy (Figure 1B). When the cell lysates were separated
by nonreducing SDS-PAGE, several V5-reactive high-molecu-
lar-weight complexes were identified, that were lost when the
samples were separated under reducing conditions and were
not present when the wild-type protein was expressed (Fig-
ure 1C). This result demonstrates the presence of mixed disul-
fides between ERdj5 C/A and endogenous proteins. To identify
these proteins, we immunoisolated V5-tagged ERdj5 and eluted
disulfide-bonded partners with the reducing agent dithiothreitol
(DTT). The eluted proteins were then digested with trypsin and
the released peptides identified by mass spectrometry (Table 1).
The formation of disulfide-linked complexes with several of the
Table 1. Mixed Disulfide Partners of ERdj5
Protein
Known
Disulfidesa
(Cysteines)
Coverageb
(%)
Present
in H63Q
ER-Resident Proteins
Peroxiredoxin-4 2 63 Y
BiP (2) 61 Y
P5 2 54 Y
ERp72 3 46 Y
ERp57 3 45 Y
PDI 2 43 Y
Ero1 6 40 Y
Erp44 2 32 Y
UDP-glucose:glycoprotein
glucosyltransferase
(13) 32 Y
ERp46 3 26 Y
Glucosidase II beta subunit (17) 15 Y
Grp94 1 13 N
Formylglycine-generating
enzyme
4 11 N
Hypoxia-upregulated
protein 1 (Grp170)
(3) 8 Y
Lysyl hydroxylase isoform 2 (9) 3 Y
Secreted Proteins
EGF-containing fibulin-like
protein 1
15 39 Y
Laminin-5 beta3 27 37 N
Transforming growth
factor-beta
5 30 N
Fibronectin 30 26 Y
Laminin subunit gamma 26 24 N
Collagen alpha-3(VI) 4 22 Y
Stanniocalcin-1 1 19 Y
Laminin B2 43 18 Y
Laminin B1 54 18 Y
Agrin 24 16 N
Granulins 5 12 N
Growth arrest-specific
protein 6
16 8 N
Pentaxin 7 7 N
Transforming growth
factor-beta binding protein
51 5 N
Collagen alpha-1(VI) (19) 4 Y
Collagen alpha-2(IV) 6 3 N
Tenascin 42 2 N
Non-ER Membrane Proteins
Low-density lipoprotein
receptor (LDLR)
30 20 Y
Low-density lipoprotein
receptor-related protein 8
27 12 Y
Death receptor 5 7 14 Y
Integrin beta-1 isoform 1A 28 12 Y
Amyloid-beta protein (12) 5 N
Table 1. Continued
Protein
Known
Disulfidesa
(Cysteines)
Coverageb
(%)
Present
in H63Q
MUC18 glycoprotein 5 4 N
NOTCH 2 115 4 N
Attractin-2 13 3 N
Mannose 6-phosphate
receptor
2 2 Y
Epidermal growth factor
receptor
25 2 N
aThe number of disulfides that are known to form are as indicated.
Where not known, the number of total cysteine residues in the protein
is in parentheses.
bThe value of percent coverage is for the C/A mutant of ERdj5.
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Mproteins identified was confirmed by their immunoisolation with
the V5 antibody and detection by western blot (Figure 1D). The
interactions were specific to exogenously expressed ERdj5, as
none of the identified substrates were immunoisolated from
untransfected cells.
The identified proteins can be categorized into three groups:
those that are resident to the ER, those that are soluble and
secreted, and those that are integral membrane proteins local-
ized to parts of the secretory pathway distinct from the ER.
The ER resident proteins include several other PDI family mem-
bers as well as PrxIV, Ero1, BiP, Grp94, and the formylglycine-
generating enzyme. The formation of mixed disulfides between
PDI family members has been seen previously (Jessop et al.,
2009b) and may reflect some disulfide exchange reactions
occurring between these proteins. PrxIV, Ero1, and the formyl-
glycine-generating enzyme all form disulfides during their reac-
tion cycles, so may require ERdj5 to break these disulfides
(Bulleid, 2012; Dierks et al., 2005). An interaction with BiP was
expected, as ERdj5 has been shown to associate with this
protein (Cunnea et al., 2003). The fact that the interaction was
released upon reduction could indicate a direct covalent link
between BiP and ERdj5, a redox dependence of the ERdj5-BiP
interaction, or an interaction between BiP and a substrate that
itself forms a covalent link to ERdj5. Interestingly, we found
that ERdj5 C/A formed a mixture of noncovalent and covalent
interactions with BiP (Figure 2A), suggesting a role for this
enzyme in the reduction of a disulfide found within BiP (Wei
et al., 2012). All of the soluble andmembrane-integrated proteins
identified contain several cysteine residues or known disulfides,
so it is likely that ERdj5 is involved in either their biosynthesis or
degradation.
Since ERdj5 is known to interact with BiP via its J domain, we
determined the consequence of preventing this association by
mutating the J domain sequence HPD to QPD.We created a sta-
ble cell line expressing the substrate-trapping mutant of ERdj5
containing the H63Q mutation. The amount of BiP associating
with ERdj5 was greatly diminished, as evidenced by the virtual
absence of BiP in the V5-isolated material from the ERdj5 C/A
H63Q compared to the ERdj5 C/A cell line (Figure 2B). However,
mixed disulfide complexes were still present in this cell line,olecular Cell 50, 793–804, June 27, 2013 ª2013 Elsevier Inc. 795
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ERdj5 Does Not Prevent Mixed Disulfide
Formation
(A) Postnuclear lysates from untransfected
HT1080 cells (UT) and ERdj5 C/A overexpression
cells were immunoisolated with the V5 antibody.
The immunoprecipitates were separated under
reducing (R) or nonreducing (NR) conditions
followed by rabbit anti-BiP western blot. Mixed
disulfides are indicated with arrows.
(B) ERdj5 was immunoisolated with the V5
antibody from cell lysates of untransfected
HT1080 cells (UT), ERdj5 C/A-overexpres-
sing HT1080 cells, and ERdj5 C/A H63Q-
overexpressing HT1080 cells. Immunoisolated
material was immunoblotted using a mouse
anti-BiP antibody. HC indicates immunoglobulin
heavy chains.
(C) Cell lysates from ERdj5 C/A- and ERdj5 C/A
H63Q-overexpressing cells were separated under
reducing (R) or nonreducing (NR) conditions and
immunoblotted using the V5 antibody.
(D) ERdj5 was immunoisolated from cell lysates of
HT1080 cells stably expressing either ERdj5 C/A
or ERdj5 C/A H63Q. Immunoisolates were
analyzed by immunoblotting with antibodies to
ERdj5 client proteins as indicated. HC and LC
(anti-Ero1 blot) indicate immunoglobulin heavy
and light chains, respectively.
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Role of ERdj5 in LDLR Folding and Secretionthough their pattern of mobility was distinctly different from the
complexes seen in the ERdj5 C/A cell line (Figure 2C). Such a
shift in mobility of the mixed disulfide complexes could reflect
a difference in the types of proteins forming mixed disulfides
with ERdj5 or may be a result of different multicomponent
complexes forming when ERdj5 is prevented from interacting
with BiP via its J domain.
Identification of the V5-immunoisolated proteins that were
eluted with DTT revealed that most of the previously identified
proteins also formed mixed disulfides with ERdj5 C/A H63Q
(Table 1). Some of the interacting partners of ERdj5 C/A H63Q
also were confirmed by carrying out a western blot following
immunoisolation of complexes with the V5 antibody (Figure 2D).
Surprisingly, BiP was identified in the eluted proteins by mass
spectrometry, even though the J domain mutation should block
noncovalent interactions, and BiP was barely detected by
western blotting in the V5-immunoisolated proteins (Figure 2B).
This result reflects the increased sensitivity ofmass spectrometry
detectionover immunodetectionbywesternblotting.Theabilityof
ERdj5 C/A H63Q to form mixed disulfides with endogenous pro-
teins would suggest that ERdj5 can function as a reductase even
in the absence of a J domain-mediated interaction with BiP.
Characterization of the ERdj5 Interaction with the LDL
Receptor
As the folding of the LDLR has been studied extensively (Gent
and Braakman, 2004; Pena et al., 2010), we decided to focus
on this protein to characterize the role of ERdj5 during protein
folding and secretion. The ectodomain of LDLR is composed796 Molecular Cell 50, 793–804, June 27, 2013 ª2013 Elsevier Inc.of three regions (Figure 3A): an amino-terminal region containing
seven ligand-binding repeats, an epidermal growth factor (EGF)
precursor homology, and an O-linked glycosylated region. The
multiple domains within LDLR previously have been shown to
fold cooperatively with the formation of intra- or interdomain,
non-native disulfides that need to be resolved to allow folding
to proceed (Jansens et al., 2002). The identification of mixed
disulfides between the LDLR and ERdj5 suggests a role for this
enzyme in reduction of disulfides, either as a prerequisite for cor-
rect folding or during degradation.
To determine the extent of mixed disulfide formation between
ERdj5 and the LDLR, we isolated V5-tagged ERdj5 from cell lines
stably expressing either the C/A or the C/A-H63Q mutant. We
then carried out western blots of the immunoisolate separated
under reducing or nonreducing conditions (Figure 3B). All of
the endogenous LDLR immunoisolated with ERdj5 was present
as a mixture of disulfide-stabilized complexes. A different
pattern of mixed disulfides was observed with the H63Q mutant
of ERdj5 C/A, indicating that a lack of BiP interaction leads to a
change in the type of mixed disulfides formed. Taken together,
these results demonstrate the ability of ERdj5 to act as a reduc-
tase for LDLR and show that although the J domain mutant
prevents BiP association, it does not prevent ERdj5 C/A from
forming a mixed disulfide complex with its substrate.
Having established that a substrate-trapping mutant of ERdj5
interacts with LDLR, we then determined whether wild-type
ERdj5 also interacts with LDLR. For these experiments, we coex-
pressed V5-tagged ERdj5 with HA-tagged LDLR and then
carried out either a V5 or HA immunoisolation followed by an
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Figure 3. ERdj5 Forms Mixed Disulfide
Complexes and Noncovalent Interactions
with LDLR
(A) Schematic of the domain organization of the
LDLR, with the positions of the class 2 mutants
used in this study indicated.
(B) ERdj5 C/A or ERdj5 C/A H63Q were im-
munoisolated with the V5 antibody from cell
lysates, separated under reducing (R) or nonre-
ducing (NR) conditions, and immunoblotted for
coisolated endogenous LDLR.
(C) Cell lysate from HT1080 cells transiently
transfected with HA-tagged LDLR (HA-LR) and
ERdj5 (dj5) was immunoblotted with the V5 anti-
body prior to (left panel) or following (right panel)
immunoisolation with the HA antibody.
(D) Cell lysate from HT1080 cells coexpressing
HA-LDLR and ERdj5 was immunoblotted with the
HA antibody prior to (left panel) or following (right
panel) immunoisolation with the V5 antibody.
(E) Same as in (C), except HT1080 cells were
cotransfected with HA-LDLR and ERdj5 H63Q.
(F) Same as in (D), except HT1080 cells were
cotransfected with HA-LDLR and ERdj5 H63Q.
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Role of ERdj5 in LDLR Folding and SecretionHA or V5 western blot of the immunoisolate (Figures 3C and 3D).
The reciprocal partner was immunoisolated in both cases,
demonstrating an interaction between these two proteins.
LDLR migrates as two species when separated by SDS-PAGE:
an ER form and a slower-migrating, Golgi-processedO-glycosy-
lated form (Jansens et al., 2002) (Figure 3D, left panel). Only the
ER form of the LDLR was immunoisolated with ERdj5, indicating
that the complex dissociates prior to transport to the Golgi
apparatus. When LDLR was coexpressed with the H63Q mutantMolecular Cell 50, 793–8of ERdj5, a similar association between
these two proteins was observed (Fig-
ures 3E and 3F). These results highlight
the physical interaction of ERdj5 with
ER-localized LDLR and show that this
interaction is not dependent on the
binding of BiP to the J-domain of ERdj5.
A comparison of the ratio of ER and
Golgi forms of LDLR coexpressed with
wild-type ERdj5 or the H63Q mutant
reveals that there is a relative abundance
of the ER form when LDLR is expressed
with the H63Q mutant (compare Figures
3D and 3F). In addition, we consistently
saw more of LDLR coimmunoisolated
when ERdj5 H63Q was coexpressed.
These results suggest a prolonged inter-
action of LDLR with the ERdj5 H63Q
mutant, resulting in retention of LDLR in
the ER.
ERdj5 and the Degradation of LDLR
There are two potential roles that the
reductase activity of ERdj5 might play
in the maturation of LDLR: either reducingdisulfides prior to degradation or reducing non-native disulfides
during productive folding. To investigate the role of ERdj5 in
degradation, we determined the contribution of ERAD to the
turnover of ER-localized LDLR. Previous studies have demon-
strated that wild-type LDLR is not subjected to ERAD; however,
some of the LDLR class 2 mutants that misfold in the ER are
degraded via this pathway (Li et al., 2004). Three such mutants
(G544V, C646Y, and P678L) were first expressed in the ERdj5
C/A cell line to see if they also formedmixed disulfides (Figure 4).04, June 27, 2013 ª2013 Elsevier Inc. 797
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Figure 4. LDLR Class 2 Mutants Interact
with ERdj5 and Are Substrates for ERAD
(A and B) ERdj5 C/A- (A) or ERdj5 C/A H63Q
(B)-overexpressing cells were transfected with
wild-type HA-LDLR or three class 2 mutants,
G544V, P678L, or C646Y. ERdj5 was immunoiso-
lated from individual transfections with the V5-
antibody; samples were separated under nonre-
ducing conditions, and any coisolated LDLR was
detected by immunoblotting with the HA antibody.
(C and D) HT1080 cells transfected with HA-tag-
ged WT or mutant LDLR were radiolabelled for
30 min and chased for 0 and 10 hr in the presence
of DMSO (control) or the proteasome inhibitors
MG132. The remaining radiolabelled LDLR was
immunoisolated from cell lysates and analyzed
under reducing conditions (C). LDLRwas detected
by phosphorimage analysis, and the percent of
HA-LDLR that was stabilized was quantified and is
shown in (D). Error bars represent ±SD for at least
three independent experiments. Asterisks depict
non-LDLR proteins, as they are also present in the
untransfected controls.
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the exogenously expressed protein from the endogenous LDLR.
The mutants formed similar patterns of mixed disulfides with
ERdj5 C/A (Figure 4A). Some of the LDLR immunoisolated with
the V5-tagged ERdj5 C/A was not present as a mixed disulfide,
indicating that it interacted noncovalently. This result contrasts
the situation with endogenous LDLR (Figure 3B), likely reflecting
the higher level of expression of LDLR following transient
transfection. When the H63Q mutant of ERdj5 C/A was coex-
pressed with LDLR, only mixed disulfide complexes were
isolated (Figure 4B). This result highlights the difference in the
mixed disulfide species formed between LDLR and either
ERdj5 C/A or ERdj5 C/A H63Q and suggests that, in the absence798 Molecular Cell 50, 793–804, June 27, 2013 ª2013 Elsevier Inc.of BiP binding, LDLR forms more pro-
longed mixed disulfides with ERdj5.
To evaluate the role of ERAD in the
degradation of both WT and the class 2
mutants of LDLR, we pulse-labeled and
incubated cells for 10 hr in the presence
or absence of the proteasome inhibitor
MG132. We immunoisolated any radiola-
belled LDLR remaining in order to
determine the level of degradation or sta-
bilization of ER-localized LDLR (Figures
4C and 4D). All three LDLR mutants
were stabilized following treatment with
MG132, confirming previous work (Li
et al., 2004) demonstrating that they are
subject to degradation by ERAD. Our
result with the wild-type protein contrasts
this previous work, as it does suggest
some stabilization of the protein in the
presence of the proteasome inhibitor.
To determine if ERdj5 plays a role in the
degradation of the class 2 mutants, wetook advantage of the previously described observation that
overexpression of ERdj5 leads to an accelerated degradation
of its substrates (Ushioda et al., 2008). We carried out a pulse-
chase analysis to follow the transport and degradation of LDLR
over a 10 hr period. No cycloheximidewas added to inhibit trans-
lation, so there was an initial increase in radiolabelled protein,
due to completion of synthesis of radiolabelled chains, followed
by a decrease in signal. For wild-type LDLR, transport of the pro-
tein from the ER to the Golgi occurred within the first hr of the
chase, followed by a steady decrease in the total signal over
10 hr (Figure 5A). Such a decrease likely reflects turnover
following endocytosis and transport to the lysosome (Brown
and Goldstein, 1975). In contrast, all of the C646Y, and most of
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Figure 5. ERdj5 Promotes ER Retention, but Not Degradation, of LDLR Class 2 Mutants
(A–C) HT1080 cells were cotransfected with either wild-type LDLR (A) or LDLR class 2 mutants C646Y (B) or G544V (C) and either an empty vector (top panel) or
ERdj5 (bottom panel). Cells were pulse labeled for 30 min and chased for the indicated times. HA-LDLR was immunoisolated from the lysates with the HA
antibody and analyzed under reducing conditions.
(D) The ER and secreted forms of the WT HA-LDLR were quantified, and the percent of the total LDLR remaining was plotted versus the indicated chase times.
(E and F) Percent of the ER form remaining for the class 2 mutants C646Y and G544V were quantified in (E) and (F), respectively. Error bars represent ±SD for at
least three independent experiments.
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Role of ERdj5 in LDLR Folding and Secretionthe G544V, mutant was retained in the ER and was not trans-
ported to the Golgi (Figures 5B and 5C). Coexpression of
ERdj5 had no effect on the transport of wild-type and did not
lead to an acceleration of degradation of either mutant or wild-
type LDLR (Figures 5D–5F). In fact, coexpression of ERdj5 actu-
ally led to a stabilization of the ER form of both LDLRmutants and
increased the retention of theG544Vmutant in the ER (Figure 5C,
compare amounts of the Golgi form in upper and lower panels).
These results suggest that ERdj5 is not involved in the degrada-
tion of misfolded LDLR, despite its association and ability to
catalyze disulfide reduction. However, lack of an accelerated
degradation of the LDLR mutants when ERdj5 is overexpressed
does not rule out a role of this protein in their degradation; rather,
it could mean that disulfide reduction is not a rate-limiting step in
the degradation of these mutants.
ERdj5 and Folding of the LDLR
The lack of an accelerated degradation of LDLR by overexpres-
sion of ERdj5 suggested that the role of ERdj5 may be to assist
correct folding. To test this possibility, cells were transfected
with either a control small hairpin RNA (shRNA) or ERdj5 shRNA
that resulted in a depletion of endogenous ERdj5 of >75% (Fig-
ure 6A). Subsequently, control and ERdj5-depleted cells wereMtransfected with HA-LDLR. Folding and trafficking of HA-LDLR
was followed by pulse-chase analysis. In the control cells, a
diffuse band for immunoisolated LDLR can be seen immediately
after the pulse (Figure 6C). Such a banding pattern is indicative of
an ensemble of disulfide-bonded species being present at early
time points, most of which are non-native disulfides (Jansens
et al., 2002). After 10 min into the chase, a more distinct band
is seen, with the appearance of the Golgi form of the protein
becoming visible after 20 min. This time course contrasted
sharply with that seen in ERdj5-depleted cells (Figure 6D).
Here, the diffuse band seen at the start of the chase remained
throughout the time course with only a small amount of protein
being transported to the Golgi even after 60 min of chase. Addi-
tional bands were also present between the ER and Golgi forms
of the protein, indicating further intermediates that failed to form
native disulfides. Hence, depletion of ERdj5 caused a dramatic
attenuation of native disulfide formation and blocked trafficking
of LDLR to the Golgi apparatus.
To further characterize the effect of ERdj5 depletion on LDLR
folding, we cotransfected cells depleted of ERdj5 with LDLR and
either wild-type, the H63Q mutant of ERdj5, or a mutant ERdj5
that had each active site mutated to AXXA (Figures 6E–6G).
Each protein was expressed at similar levels, with each presentolecular Cell 50, 793–804, June 27, 2013 ª2013 Elsevier Inc. 799
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Figure 6. shRNA Knockdown of Endogenous ERdj5 Compromises Native Disulfide Bond Formation and Secretion of LDLR
(A) HT1080 cells were treatedwith either ERdj5-specific or scrambled shRNA as indicated, and the level of ERdj5 remaining after 5 days was quantified using actin
as a loading control.
(B) Comparison of the level of ERdj5 in ERdj5 knockdown cells transfected with various ERdj5 constructs as indicated. Level of expression compared to non-
depleted cells is as indicated.
(C) HT1080 cells were treated with scrambled shRNA for 5 days and then cotransfected with HA-LDLR and empty vector. After a further 24 hr, cells were pulse
labeled for 30 min and chased for the indicated times. Radiolabelled LDLR was immunoisolated from the cell lysate with the HA antibody and analyzed under
nonreducing conditions.
(D–G) HT1080 cells were treated with shRNA directed against ERdj5 then cotransfected with HA-LDLR and either empty vector (D), ERdj5 (E), ERdj5 H63Q (F), or
ERdj5 AXXA mutant (G). Cells were pulse labeled for 30 min, and radiolabelled LDLR was isolated from the cell lysate and analyzed as in (C). The ER and Golgi
forms are indicated as well as disulfide-bonded intermediates.
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Role of ERdj5 in LDLR Folding and Secretionat between 83 and 103 the level of endogenous ERdj5 prior to
knockdown (Figure 6B). The ERdj5 constructs used have an
altered codon bias to the endogenous gene and are not targeted
by the shRNA. Coexpression of wild-type ERdj5 resulted in a
reversal of the defect seen following shRNA depletion, with effi-800 Molecular Cell 50, 793–804, June 27, 2013 ª2013 Elsevier Inc.cient formation of the correctly disulfide-bonded protein and
trafficking to the Golgi (Figure 6E). However, cotransfection
with the H63Q mutant of ERdj5 did not reverse the defect. In
fact, a significant amount of the protein was present as high-
molecular-weight aggregates that resided at the top of the
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Figure 7. shRNA Knockdown of Endogenous ERdj5 Does Not Affect
General ER Folding or Secretion
(A and B) V5-tagged QSOX-1B was transiently transfected into HT1080 cells
treated with scrambled shRNA (A) or ERdj5-specific shRNA (B). After 24 hr,
cells were pulse labeled for 30 min and chased as indicated. Radiolabelled
QSOX was immunoisolated from the cell lysate and medium with the V5
antibody and analyzed under reducing SDS-PAGE.
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Role of ERdj5 in LDLR Folding and Secretionseparating gel (Figure 6F). In addition, the AXXA mutant of
ERdj5 could not reverse the defect seen in LDLR folding, giving
a very similar pattern of intermediates seen following knockdown
(Figure 6G). These results demonstrate that the effect of
ERdj5 depletion on LDLR folding is due to the absence of
ERdj5 and that the disulfide exchange activity of ERdj5 is
required to reverse the folding defect. Moreover, the reversal
of the knockdown phenotype is dependent on the interaction
of ERdj5 with BiP.
To determine whether the effect of ERdj5 on LDLR folding
could be explained by a general defect in the trafficking of pro-
teins following knockdown, we investigated the trafficking of a
non-ERdj5 substrate. A V5-tagged version of human QSOX1B
was used, as it is a soluble glycoprotein containing no structural
disulfides (Alon et al., 2012) and becomes modified in the Golgi
apparatus, allowing its trafficking and secretion to be monitored
(Figure 7A). The ER form of the protein migrates as three distinct
bands representing different glycoforms. The Golgi form of the
protein becomes evident 20min after the end of the pulse, which
coincides with its appearance in the medium, indicating efficient
trafficking and secretion. When the same experiment was car-
ried out in ERdj5-knockdown cells, no effect was evident on
the trafficking or secretion of QSOX1B (Figure 7B). These results
demonstrate that ERdj5 knockdown does not cause a general
defect in protein trafficking.
DISCUSSION
The substrate-trapping mutants of thioredoxin domain-contain-
ing proteins have been used successfully in the past to identify
novel substrates for this family of enzymes (Jessop et al.,
2007, 2009b; Zito et al., 2010). Here, we have extended these
studies to determine the potential endogenous substrates for
ERdj5. The isolation of proteins forming mixed disulfides with
ERdj5 indicates that the enzyme is able to reduce either a pre-
existing disulfide bond or a cysteine modified by sulfenylation
or nitrosylation. Susceptible disulfides or modified cysteines
are likely to be exposed at the protein surface to allow accessMby the enzyme. Mixed disulfides with ER-resident proteins
known to contain solvent-accessible cysteines was not unex-
pected, though the formation of mixed disulfides with several
PDI family members indicates that exchange of disulfides
between these enzymes can occur. Since ERdj5 contains a
thioredoxin domain with the lowest reduction potential of the
PDI-family (Hagiwara et al., 2011), it might function to maintain
the other PDIs in a reduced state, allowing them to participate
in isomerization or reduction reactions. In support of such a
hierarchy of disulfide exchange reactions is the fact that previous
work with substrate-trapping mutants of PDI family members
identified some mixed disulfides between PDIs, but never with
ERdj5 (Jessop et al., 2009b). Hence, ERdj5 can reduce several
other members of the family, but no other member can reduce
ERdj5, despite it being present in the ER predominantly in an
oxidized state (Riemer et al., 2009). How ERdj5 is itself reduced
once its active site is oxidized remains unknown but may involve
equilibration with the glutathione buffer in the ER lumen (Bulleid
and Ellgaard, 2011).
Our results provide an indication of the breadth of endogenous
proteins that can form mixed disulfides with ERdj5. The identifi-
cation of these potential substrates is a crucial starting point to
evaluate the function of this disulfide exchange protein in the
biosynthesis of proteins entering the secretory pathway. As
most of the previous work on this protein has focused on its
role in degradation (Hagiwara et al., 2011; Ushioda et al., 2008),
it is intriguing that our results demonstrate that its role is more
extensive, being required for the efficient folding of the LDLR.
The formation of the correct disulfides in this protein is likely to
be a complex process requiring several different enzymes and
ER chaperones. The specific role of ERdj5 in the folding of
LDLR potentially is to reduce the non-native disulfides formed
as an obligatory requirement for the correct folding of the protein
(Jansens et al., 2002). This role is best exemplified during ERdj5
knockdown, which resulted in the perseverance of non-native
disulfides in LDLR. As ERdj5 lacks the ability to isomerize disul-
fides (Ushioda et al., 2008), there would be a requirement for a
second PDI family member to catalyze disulfide formation. It pre-
viously has been shown that ERp57, P5, and ERp46 also form
mixed disulphideswith LDLR (Jessop et al., 2009b), and it is high-
ly likely that PDI itself is involved in catalyzing disulfide formation.
While the catalytic function of ERdj5 is as a reductase, we have
shown that it can also associate noncovalently with its substrate.
Crucially, the stable interaction between ERdj5 and LDLR was
not dependent on the presence of the active-site, substrate-
trapping mutation and was not abolished when BiP binding to
the J domain was prevented. Indeed, the H63Q mutant of
ERdj5 formed a more prolonged interaction with LDLR and
increased ER residence. In addition, overexpression of ERdj5
caused a stabilization of the LDLR mutants, suggesting that
binding of ERdj5 prevented entry into the ERAD pathway. These
results strongly indicate that ERdj5 can act as a polypeptide-
binding protein; its physical association with folding intermedi-
ates of LDLR may help to retain it in the ER, allowing correct
disulfides and domain folding to occur. The ability of ERdj5 to
bind to polypeptides is similar to a previously suggested role
for PDI during the folding of procollagen (Wilson et al., 1998)
and might be a general function of all the PDI family members.olecular Cell 50, 793–804, June 27, 2013 ª2013 Elsevier Inc. 801
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ERdj5 is not dependent on its ability to interact with BiP via its
J domain. However, the reversal of the folding defect seen
upon ERdj5 knockdown requires both its disulfide exchange
activity and an interaction with BiP. Hence, the essential function
of ERdj5 requires BiP binding via its J domain. One possible role
for BiP in this regard would be to facilitate the release of ERdj5
from its substrate, as is the case for the release of ERdj3 from
its substrate (Jin et al., 2008). The absence of BiP binding would
cause prolonged ERdj5 binding and compromise its ability to act
as a reductase or to allow other PDI family members access to
LDLR to catalyze disulfide formation. Preventing BiP binding to
ERdj5 also abolished the accelerated degradation of ERAD sub-
strates upon overexpression of ERdj5 (Ushioda et al., 2008).
Hence, for a productive role in both degradation and folding,
ERdj5 needs to be able to bind to BiP via its J domain.
The identification of BiP as an interacting partner of ERdj5
binding via the J domain is entirely consistent with previous
results (Cunnea et al., 2003). It recently has been shown that
BiP itself may form a reversible disulfide bond that could influ-
ence its chaperone function (Wei et al., 2012). Therefore, an
alternative explanation for our identification of BiP as a partner
of the substrate-trapping mutant of ERdj5 that is released
upon treatment with reducing agent could be more complex
than simply due to BiP’s interaction with misfolded ERdj5
substrates. If BiP does form an internal intrachain disulfide to
regulate its chaperone activity, then this disulfide may well be
reduced by a PDI family member such as ERdj5. In support of
such a role for ERdj5, we show here that the ERdj5 C/A mutant
can form a mixed disulfide with BiP.
The reason for the presence of such a large family of oxidore-
ductases in the ER of mammalian cells has been speculated to
be due to either substrate specificity or the ability to catalyze
specific types of disulfide exchange (Hatahet and Ruddock,
2007). Both our previous results and those reported here demon-
strate that there is not a clear demarcation between each
enzyme in terms of their substrate specificity (Jessop et al.,
2009b). ERdj5 is the only member of the PDI family so far whose
function can be assigned to reduction of disulfides or reversibly
modified cysteines. Such a reductase activity is required to
ensure the correct folding of proteins entering the secretory
pathway or in preparing misfolded proteins for dislocation to
the cytosol for degradation.
EXPERIMENTAL PROCEDURES
Expression Plasmids, Antibodies, and Inhibitors
A human ERdj5 DNA construct with CXXA mutation in the four thioredoxin
homologous domains was synthesized by GenScript. A construct that
included a V5 tag at the C terminus followed by a KDEL sequence was subcl-
oned into pcDNA 3.1 (Invitrogen). The wild-type, AXXA, and H63Q mutants
were generated using the appropriate primer pairs. The wild-type HA-tagged
LDLR was from Guojun Bu (Mayo Clinic). V5-tagged QSOX1B was generated
from QSOX1A constructed as described previously (Chakravarthi et al., 2007).
The class 2 mutants G544V, P687L, and C646Y were generated from this
construct using the appropriate primer pairs.
The commercially sourced antibodies used were mouse monoclonals (anti-
HA [Sigma-Aldrich], anti-V5 [Invitrogen], anti-V5-conjugated agarose beads
[Sigma-Aldrich], and anti-BiP [BD Transduction Laboratories]); rabbit mono-
clonals (anti-LDLR [C-terminal] and anti-UGGT1 [Epitomics]); and rabbit poly-802 Molecular Cell 50, 793–804, June 27, 2013 ª2013 Elsevier Inc.clonals (anti-actin [Sigma-Aldrich], anti-human a1AT [Dako], and anti-PrxIV
[Abfrontier]). The Ero1a monoclonal antibody, 2G4, was from Roberto Sitia
(San Raffaele Scientific Institute) (Ronzoni et al., 2010). The rabbit anti-ERdj5
was from Giannis Spyrou (Foundation for Biomedical Research, Academy of
Athens) (Thomas and Spyrou, 2009). The rabbit anti-BiP antibody was from
Richard Zimmerman (Universita¨t des Saarlandes, Homburg) (Scha¨uble et al.,
2012). Rabbit polyclonal antibodies for P5, PDI, and ERp57 have been
described previously (Jessop and Bulleid, 2004).
Cell Culture, Transfections, and shRNA Knockdown
HT1080 cells were maintained in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% fetal bovine serum (FBS). Cells were trans-
fected with DNA using polyethylenimine (PEI) (Durocher et al., 2002). To create
stable overexpression cells, transfected cells were placed on antibiotic (G418)
selection for approximately 2 weeks until colonies appeared. For the shRNA-
mediated knockdown, a human ERdj5-specific shRNA or a scrambled shRNA
in pGFP-V-RS vector (OriGene) was transfected into subconfluent HT1080
cells. After 24 hr, shRNA-transfected cells were selected with 0.5 mg/ml puro-
mycin for at least 5 days.
Immunofluorescent Microscopy
Typically, HT1080 human fibroblast cells stably expressing ERdj5-V5 C/A
mutant were permeabilized and fixed with methanol. Cells were labeled with
a rabbit anti-PDI antibody andmouse anti-V5 antibodies, which were detected
with the appropriate fluorescein isothiocyanate (FITC; Sigma-Aldrich) and
Texas red (Abcam) secondary antibodies. Cells were imaged using a Zeiss
Laser-Scanning Microscope (LSM) 5 Exciter.
Mass Spectrometry
Confluent HT1080 cells and HT1080 cells stably overexpressing substrate-
trapping ERdj5-V5 and the H63Q mutant were rinsed twice with PBS contain-
ing 20 mMN-Ethylmaleimide (NEM). Cells were lysed in 50 mM Tris-HCl buffer
(pH 7.4) containing 1% (v/v) Triton X-100, 150 mM NaCl, 2 mM EDTA, and
0.5 mM phenylmethylsulfonyl fluoride (PMSF) supplemented with protease
inhibitor cocktail (Roche). Clarified lysates were preincubated with protein A
sepharose (Generon) before incubation with anti-V5-conjugated agarose
beads (Sigma-Aldrich) for 16 hr at 4C. Immunoisolates were washed three
times with lysis buffer before incubation with 10 mM DTT for 5 min. The
samples were centrifuged at 16,000 3 g for 10 min to recover the eluted pro-
teins, whichwere precipitatedwith 12% (w/v) trichloroacetic acid. Precipitated
protein was solubilized in 25 mM ammonium bicarbonate and digested with
trypsin.
Peptides were diluted 1:2 with 0.1% formic acid and separated using an
UltiMate Nano LC (LC Packings) equipped with a PepMap C18 trap using a
gradient of increasing acetonitrile concentration containing 0.1% formic
acid. The eluate was sprayed into a QStar XL tandem mass spectrometer
(AB SCIEX) and analyzed in the information-dependent acquisition mode;
1 s mass spectrometry (MS) followed by 3 s tandem mass spectrometry
(MS/MS) was performed, analyzing the two most intense peaks seen by MS.
These masses were then excluded from analysis for the next 60 s. MS/MS
data for doubly and triply charged precursor ions were converted to centroid
data, without smoothing, using the Analyst QS1.1 mascot.dll data import filter
with default settings. The MS/MS data file generated was analyzed using the
Mascot 2.1 search engine (Matrix Science) against the NCBInr database
(February 2011; 12852469 sequences) with no species restriction. The data
were searched with tolerances of 0.2 Da for the precursor and fragment
ions, trypsin as the cleavage enzyme, one missed cleavage, NEMmodification
of cysteines as a fixed modification, and methionine oxidation selected as a
variable modification. The Mascot search results were accepted if a protein
hit included at least two peptides with ion scores above the homology
threshold.
Immunoisolation and Western Blots
Immunoisolation was performed by preclearing the cell lysates with protein A
sepharose for 30 min, followed by incubation with the appropriate antibody
and protein A sepharose for 16 hr at 4C. Beads were washed three times
in lysis buffer. Washed beads were heated at 95C for 5 min in 200 mM
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Role of ERdj5 in LDLR Folding and SecretionTris-HCl buffer (pH 6.8), 3% SDS, 10% glycerol, 1 mM EDTA, and 0.004%
bromophenol blue in the presence (reducing) or absence (nonreducing) of
50 mM DTT prior to SDS-PAGE.
For western blotting, proteins were transferred to nitrocellulose mem-
branes (LI-COR Biosciences), which were blocked in 5% (w/v) dried milk in
10 mM Tris-HCl buffer (pH 7.5) containing 150 mM NaCl and 0.1% (v/v)
Tween 20 for 1 hr. Blots were incubated with primary antibody for 1 hr. LI-COR
IRDye fluorescent secondary antibodies were used for detection at a 1:5,000
dilution. Blots were scanned using an Odyssey Sa Imaging System (LI-COR
Biosciences).
Metabolic Labeling and Pulse-Chase Analysis
HT1080 cells transfected with plasmids were incubated in medium lacking
methionine and cysteine for 30 min and pulse labeled for 30 min with 11 mCi/
ml of EXPRESS35S Protein Labeling Mix (PerkinElmer). The radiolabel was
removed with two PBS washes. The cells were then incubated in complete
medium to initiate the chase periods. To monitor the degradation of wild-
type HA-LDLR and the class 2 mutants, transfected cells were incubated
with or without MG132 (20 mM) in the medium during the starve, label, and
chase periods.
Following the chase period, cells were washed twice with PBS supple-
mented with 20 mM NEM and lysed in lysis buffer containing 20 mM NEM.
Postnuclear supernatant was obtained by centrifugation at 4C, and immunoi-
solation was carried out as described above. SDS-PAGE gels were fixed,
dried, and exposed to phosphorimager plate for between 24 and 72 hr. Radio-
activity was detected using a Fujifilm FLA-7000 Phosphorimager. Quantifica-
tion of band intensities was carried out using ImageJ software.
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